http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101622454-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2014-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101622454-B1 |
| titleOfInvention | Predictive biomarkers for EGFR tyrosine kinase inhibitors as anticancer therapy |
| abstract | The present invention provides an information providing method for predicting the prognosis of cancer treatment by EGFR tyrosine kinase inhibitor, a composition for predicting the prognosis of cancer treatment, and a kit. According to the present invention, since the prognosis of cancer treatment by EGFR tyrosine kinase inhibitor can be predicted by measuring the level of expression of one or more genes or proteins selected from the group consisting of IL6, IL8, PLA2G2A, IL1A, TNF, MMP3 and PTGS2, And can be usefully used for drug selection for treatment. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190037071-A |
| priorityDate | 2014-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.